3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
70
Phase 3
18
Phase 1/2
12
Phase 1
9
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Oxaliplatin
15
Fluorouracil
13
Bevacizumab
13
Leucovorin
10
Capecitabine
8
Folfox protocol
7
Irinotecan
6
IFL protocol
4
Cetuximab
4
Folic Acid
3
Aspirin
3
atezolizumab
2
XELOX
2
Surgical Procedures, Operative
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
trifluridine tipiracil drug combination
1
trametinib
1
titanium silicide
1
sulindac sulfone
1
spartalizumab
1
sacituzumab govitecan
1
regorafenib
1
raltitrexed
1
pertuzumab
1
irinotecan sucrosofate
1
folfirinox
1
envafolimab
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Colorectal Neoplasms
×
Panitumumab
×
Clear all
NCT00647530
2019-05-17
FOxTROT
University of Birmingham
Phase 2/3
Unknown
1,053 enrolled